MAPT and Mental deterioration: In this context, ML and DL trained on 18F-FDG PET, Amyloid PET, and Tau PET imaging have shown promise in early diagnosis of AD, in predicting MCI conversion, in tracking disease progression, and in predicting cognitive decline trajectories.